Document is current
Any future updates will be listed below
-
Authors
Jain, Tania https://orcid.org/0000-0001-6854-773X
Kunze, Katie L. https://orcid.org/0000-0001-6850-6823
Mountjoy, Luke
Partain, Daniel K.
Kosiorek, Heidi
Khera, Nandita
Hogan, William J. https://orcid.org/0000-0002-5841-4105
Roy, Vivek
Slack, James L.
Noel, Pierre
Fauble, Veena D. S.
Leis, Jose F.
Sproat, Lisa
Tefferi, Ayalew
Patnaik, Mrinal M.
Mesa, Ruben A.
Palmer, Jeanne
-
Funding
Funding for this research was provided by:
Defense Health Board (Member), Entegrion (Board of Directors), Vitalant (Board of Directors), Securisyn (Royalties), Novartis Pharmaceuticals
- License Information
-
More Information
Article History
Received: 6 December 2019
Revised: 17 January 2020
Accepted: 24 January 2020
First Online: 10 March 2020
Conflict of interest
: P.N.: Defense Health Board (Member), Entegrion (Board of Directors), Vitalant (Board of Directors), Securisyn (Royalties), Novartis Pharmaceuticals (spouse is an employee). R.A.M.: (Consultant) Novartis, Sierra Onc, LaJolla, Pharma; (Research Support) Celgene, Incyte, Abbvie, Samus, Genotech, Promedior, CTI.
